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Ophthalmic Manifestations of Congenital Zika Syndrome
in Colombia and Venezuela
Juan B. Yepez, MD; Felipe A. Murati, MD; Michele Pettito, MD; Carlos F. Peñaranda, MD; Jazmin de Yepez, MD;
Gladys Maestre, MD; J. Fernando Arevalo, MD; for The Johns Hopkins Zika Center

IMPORTANCE The ocular manifestations and sequelae of Zika virus infection are not well

known. Recently, the World Health Organization changed the declaration of Zika as a public
health emergency and designated the viral outbreak and related microcephaly clusters as a
long-term program of work. This change indicates the urgent need to evaluate and document
ophthalmic manifestations in patients for timely management of this disease. In addition,
confirmation whether the public health problem in Brazil extends to other regions in South
America is needed.
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OBJECTIVE To report the ocular manifestations of congenital Zika syndrome with
microcephaly in Colombia and Venezuela.
DESIGN, SETTING, AND PARTICIPANTS This prospective case series included 43 patients from
2 ophthalmic centers in Colombia and Venezuela who underwent evaluation from October 1,
2015, through June 30, 2016, and were clinically diagnosed with congenital Zika syndrome.
Twenty patients were Hispanic; 13, African; 8, white; and 2, Native American.
INTERVENTIONS Ophthalmic and systemic evaluations and serologic testing were performed

on all infants. Patients underwent external ocular examination and dilated ophthalmoscopy.
Serologic testing ruled out toxoplasmosis, rubella, cytomegalovirus, syphilis, and human
immunodeficiency virus.
MAIN OUTCOMES AND MEASURES Ophthalmic manifestations of congenital Zika syndrome.
RESULTS Of the 43 patients included in this series (28 female and 15 male), the mean (SD) age
at examination was 2.1 (1.5) months. The mothers of all the children had no ophthalmic
findings and did not report ocular symptoms during pregnancy. All patients had bilateral
ophthalmic manifestations. Optic nerve findings included hypoplasia with the double-ring
sign, pallor, and increased cup-disc ratio in 5 patients (11.6%). Macular abnormalities included
mild to severe pigment mottling in 27 patients (63%) and lacunar maculopathy in 3 (6.9%).
Chorioretinal scarring was present in 3 patients (7%). Eleven patients (26%) had a
combination of lesions in the posterior pole. Five patients (12%) were diagnosed with
congenital glaucoma, characterized by the clinical triad of epiphora, photophobia, and
blepharospasm; increased intraocular pressure; corneal clouding at birth; and buphthalmos.
These data reveal that 12% (95% CI, 5%-24%) of cases of congenital Zika with microcephaly
had anterior segment abnormalities and 88% (95% CI, 76%-94%) had important macular
and optic nerve abnormalities. The visual sequelae of these ophthalmic manifestations
remain unknown.
CONCLUSIONS AND RELEVANCE Congenital Zika syndrome in the current study had severe
ocular abnormalities, and all patients had bilateral involvement. Ocular findings were focal
macular pigment mottling, chorioretinal atrophy with a predilection for the macular area,
congenital glaucoma and optical nerve hypoplasia, and optic disc abnormalities. Ophthalmic
examination is recommended in patients with congenital Zika syndrome.
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T

he Zika virus was isolated in monkeys in the Ugandan
Zika forest in the 1940s1 and identified in humans in the
1950s in Africa.2 For most of the 21st century, Zika virus infection was extremely rare outside Africa. This relative
obscurity was attributable to the lower prevalence and similarity of Zika virus infection to other more common mosquitoborne flaviviruses such as dengue and chikungunya. An epidemic of Zika virus occurred in Micronesia in 2007, which was
the first outbreak outside Africa.3 The epidemic was considered to be benign because most of the infections (80%) yielded
only mild symptoms that were reminiscent of the betterknown dengue or chikungunya, including rash, fever, arthralgia, headaches, and conjunctivitis. The duration of symptoms generally ranged from 5 to 10 days, with no apparent
long-term sequelae.3
More outbreaks of Zika virus occurred in the Pacific Islands region from 2013 to 2014. An epidemic in French Polynesia included the first published cases of Zika virus–related
Guillain-Barré syndrome.4 By 2014, Zika virus had spread to
South America, and an association with Guillain-Barré syndrome was reported in Brazil.5 In addition, the alarming new
finding of cases of microcephaly was reported in the infants
of Zika virus–infected mothers.6 The current scientific consensus is that Zika virus was the likely cause of microcephaly
in these infants.7 Since May 2015, Zika virus has spread from
South America to Central America, Puerto Rico, the United
States, and the US Virgin Islands. More than 1 million cases of
Zika virus infection have been reported in Central and South
America. In addition, the neurologic manifestations of this viral infection are still evolving. Therefore, the World Health Organization declared Zika virus infection to be a Public Health
Emergency of International Concern.8 However, in November 2016, the World Health Organization changed the declaration of Zika virus infection as a public health emergency and
stated that the Zika virus outbreak and related clusters of microcephaly are no longer a Public Health Emergency of International Concern. This change in the declaration does not
downgrade the importance of Zika virus but designates it as a
focus for a long-term program of work.9
Diagnosis of Zika virus infection is problematic owing to
the similar presentation of the virus to other flaviviruses, its
self-limited nature, and its serologic cross-reactivity with other
flaviviruses. Polymerase chain reaction assays can detect Zika
virus RNA within the first week of infection but have limited
usefulness beyond that time frame. Serologic testing for Zika
virus IgM has high cross-reactivity with other flaviviruses. The
plaque reduction neutralization test has greater specificity.10
In Colombia, a country with a population of 48 million,
Aedes aegypti and Aedes albopictus mosquitoes are most commonly found at elevations below 2000 m. A recent preliminary report by Pacheco et al11 found that before April 2016,
65 726 cases of Zika virus infection were reported in Colombia. Transmission of the Zika virus from mother to fetus and
sexual transmission have been reported. The first outbreak of
Zika virus infection in continental South America occurred in
Brazil, where autochthonous transmission was confirmed in
May 2015. Although preliminary monitoring began in Colombia after recognition of the Brazilian outbreak, the Colombian
jamaophthalmology.com
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Key Points
Question What are the ophthalmic manifestations in infants with
microcephaly associated with clinically diagnosed Zika virus in
Colombia and Venezuela?
Findings In this case series of 43 patients, substantial anterior and
posterior segment abnormalities, including congenital glaucoma,
were found in 5 (12%) and macular or optic nerve abnormalities in
38 (88%).
Meaning These findings suggest that all infants with
microcephaly associated with clinically diagnosed Zika virus should
undergo evaluation for ophthalmic findings.

Instituto Nacional de Salud began official surveillance for Zika
virus infection in August 2015.11-14
In Venezuela, a country with a population of 30 million, a
recent report by the Venezuelan Society of Public Health estimates that the number of probable cases of Zika virus infection from 2015 to the beginning of April 2016 was 723 550 (23.6
per 1000 population), with hundreds of these cases occurring
with Guillain-Barré syndrome.15 Although severe ocular complications have not been reported, tertiary ophthalmic clinics
have observed severe multiple complications beyond typical
conjunctivitis after symptomatic infection typical of the Zika
virus.15,16 However, the prevalence of Zika virus infection in Colombia and Venezuela is still presumptive because definitive serologic testing for Zika virus was not available at the time. Therefore, the prevalence of Zika virus infection cited herein includes
all the patients who were reported to the National Institute of
Health in Colombia and Venezuela with symptoms of Zika virus infection with and without laboratory confirmation.
Microcephaly can be genetic, metabolic, drug related, or
due to perinatal insults, such as hypoxia, malnutrition, or infection. The 20-fold increase in cases of microcephaly
reported in parts of Brazil is temporally associated with the outbreak of Zika virus. However, this association is still presumptive because definitive serologic testing for Zika virus was not
available in Brazil at the time of the outbreak and other causes
of microcephaly may also have been mistakenly included.17
Other reports have been published on patients with Zika virus infection with ocular manifestations.17,18 An evaluation of
58 eyes in 29 infants by de Paula Freitas et al16 indicated bilateral findings in 7 of 10 patients with ocular lesions, with a
prevalence of 34.5%. Recently, a case of glaucoma in a patient
with congenital Zika syndrome was reported.19 The objective
of the present study is to report the ophthalmic manifestations in infants with congenital Zika syndrome in Maracaibo,
Venezuela, and Cúcuta, Colombia.

Methods
This prospective case series evaluated 43 infants with congenital Zika syndrome at Clinica de Ojos in Maracaibo, Venezuela, and Clinica Oftalmológica Peñaranda in Cúcuta, Colombia. Ophthalmic evaluation was performed from October
1, 2015, through June 30, 2016. This study was approved by
(Reprinted) JAMA Ophthalmology May 2017 Volume 135, Number 5

Copyright 2017 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ by a University of Texas - Rio Grande Valley User on 02/06/2020

441

Research Original Investigation

Ophthalmic Manifestations of Congenital Zika Syndrome

the institutional ethics committee at both study centers. Written informed consent for this study was obtained from the parents of all infants. The study and data collection adhered to
the tenets of the Declaration of Helsinki.20
All infants and mothers underwent systemic and retinal
examinations and documentation with fundus imaging. Inclusion criteria consisted of mothers with suspected Zika virus infection and a cephalic circumference of 32 cm or less at
birth. Other congenital infections included in the differential
diagnosis were TORCH, which includes toxoplasmosis, other
infection (syphilis, varicella-zoster, or parvovirus B19), rubella, cytomegalovirus infection, and herpes simplex virus infection, and human immunodeficiency virus infection. These
diseases were ruled out through serologic testing. In all cases,
specific tests were performed as part of routine screening that
included serologic testing of mothers. The suspected diagnosis of congenital Zika virus infection was also based on clinical features of the mothers during pregnancy, including cutaneous rash, fever, arthralgia, headache, itch, and malaise.
Newborn infants were excluded if they had a cephalic diameter that exceeded 33 cm, evidence of other congenital infections such as TORCH or human immunodeficiency virus,
or a familial history of microcephaly. All mothers underwent
Figure 1. Optic Nerve Hypoplasia

Representative ophthalmoscopy in the left eye of a patient with congenital Zika
syndrome demonstrates optic nerve hypoplasia with the double-ring sign (open
triangle) and disc pallor.

an external ocular examination, biomicroscopy, and dilated indirect ophthalmoscopy. All infants underwent an ocular external examination and indirect ophthalmoscopy. Optic nerve,
retinal, and choroidal abnormalities were documented with use
of a wide-field digital imaging system (RetCam Shuttle; Clarity Medical Systems, Inc) after pupillary dilation.
Data were collected in an Excel 2011 spreadsheet (Microsoft Corp) and statistically analyzed with MedCalc software
(version 8.2.0.3; MedCalc). Continuous data are presented as
means and categorical data as numbers and percentages. Patients’ cup-disc ratio and corneal diameter were transferred
from their records and converted to means for analysis. We
used the paired t test to compare mean values. Correlation was
considered significant with P < .05. The 95% CIs were calculated using assumptions based on the Poisson distribution.

Results
Forty-three infants with microcephaly, ocular findings, and a
clinical diagnosis of Zika virus vertical infection underwent
evaluation. Mean (SD) age on the day of the examination was
2.1 (1.5) months (range, 0.2-6.6 months). Twenty-eight patients (65%) were female, and 15 (35%) were male. Twenty patients were Hispanic; 13, of African descent; 8, white; and 2,
of Native American origin. All the patients were born during
the Zika virus outbreak in Colombia and Venezuela, and all the
mothers were clinically diagnosed with Zika virus infection,
defined by denguelike symptoms (malaise, rash, and arthralgia) during pregnancy. Thus, the infants were clinically diagnosed with presumed intrauterine Zika virus infection (congenital Zika syndrome). Infants with microcephaly with a
presumed diagnosis of congenital Zika syndrome were recruited through an active search and referrals from other hospitals and health centers. None of the mothers presented with
any ocular findings. All infants presented with bilateral ocular findings. Five infants (12%) had hypoplasia of the optic nerve
with the double-ring sign, pallor, and increased cup-disk ratio (Figure 1). The macular abnormalities were mild to severe
pigment mottling in 27 infants (63%) (Figure 2) and lacunar
maculopathy in 3 (7%), defined as diffuse lacunar chorioretinal dysplasia. Chorioretinal scarring was present in 3 infants
(7%) (Figure 3). Eleven patients (26%) had a combination of

Figure 2. Severe Pigment Mottling
A Patient A

B

Patient B

Representative ophthalmoscopy in
the left eyes of 2 patients with
congenital Zika syndrome
demonstrates macular chorioretinal
atrophy (open triangles) and focal
pigment mottling (arrowheads).
442

JAMA Ophthalmology May 2017 Volume 135, Number 5 (Reprinted)

Copyright 2017 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ by a University of Texas - Rio Grande Valley User on 02/06/2020

jamaophthalmology.com

Ophthalmic Manifestations of Congenital Zika Syndrome

Original Investigation Research

lesions in the posterior pole. Five infants (12%) had congenital glaucoma characterized by the clinical triad of epiphora,
photophobia, and blepharospasm; increased intraocular pressure to a mean of 57.4 mm Hg (range, 49.8-76.1 mm Hg); corneal clouding at birth; and buphthalmos (enlargement of the
eye) (Figure 4 and Table). In total, 12% (95% CI, 5%-24%) of
cases had anterior segment abnormalities, and 88% (95% CI,
76%-94%) had important macular and optic nerve abnormalities. No other retinal manifestations were found. The retina
remained attached in all cases. No cases of anterior uveitis were
found in this series of patients.

Discussion
This study of the ophthalmic manifestations of congenital Zika
syndrome found various abnormalities. These findings included focal pigment mottling with a predilection for the macular area, optic disc hypoplasia, lacunar maculopathy, and chorioretinal scars. In the present study, 5 infants presented with
congenital glaucoma associated with Zika virus infection.
To our knowledge, this case series is the first to report congenital glaucoma associated with congenital Zika syndrome.
de Paula Freitas et al19 recently reported the first case of glaucoma associated with congenital Zika syndrome. Based on our
findings, we agree with de Paula Freitas et al16 that all infants
with microcephaly should undergo a routine ophthalmic examination, and every infant with microcephaly in countries
with a high prevalence of Zika should undergo evaluation for
abnormal ocular changes.
Zika virus is a mosquito-borne flavivirus transmitted by
A aegypti and A albopictus, which are also vectors for dengue
and chikungunya. The emergence of Zika virus worldwide, especially in tropical countries including Venezuela, coincided
with increased reports of newborns with microcephaly, congenital malformations, and neurologic syndromes. The declaration on Zika virus by the World Health Organization in February 2016 was to the result of the rapid spread of Zika virus
infection. Therefore, only cases with microcephaly were classified as presumed cases of congenital Zika virus infection and
further investigated.16 A recent case report proposes that microcephaly should not be a required criterion for diagnosing
congenital Zika virus infection.17

Zika virus infection causes a self-limited denguelike illness
characterized by exanthema, low-grade fever, conjunctivitis, and
arthralgia, although it may be asymptomatic in some cases.17,18
Some of the ophthalmic findings in the present study concur with
those of previous reports.19,21,22 For example, chorioretinal scarring in the macular region has been reported in congenital Zika
virus infection.17 de Paula Freitas et al16 described 17 eyes affected
by Zika virus with microcephaly; ophthalmic findings included
focal pigment mottling, chorioretinal atrophy, optic nerve abnormalities, iris coloboma, and lens subluxation. Our finding of congenital glaucoma in association with an epidemic of systemic
disease is similar to the experience with congenital rubella
syndrome.23 A follow-up study of 125 patients with congenital
rubella syndrome23 evaluated the association between ophthalmic disorders and systemic disease and reported that 9% of the
patients had congenital glaucoma. Transplacental transmission
of West Nile virus has been previously reported,24 resulting in
lesions somewhat similar to those described in the present study,
such as macular granular appearance and chorioretinal scarring.
The differential diagnosis of chorioretinal lesions such as those

Figure 3. Chorioretinal Scarring

Representative ophthalmoscopy in the left eye of a patient with congenital Zika
syndrome demonstrates a chorioretinal scar with macular retinal pigment
epithelium hypopigmentation and scarce pigment surrounding 2 sharp areas of
hypopigmentation (lacunae) with pigmentation in their borders and 250 μm
and 500 μm in size.

Figure 4. Bilateral Congenital Glaucoma
A Right eye

B

Left eye

A patient with bilateral congenital
glaucoma had the clinical triad of
epiphora, photophobia, and
blepharospasm; increased intraocular
pressure; corneal clouding at birth;
and buphthalmos in both eyes.
jamaophthalmology.com
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Table. Findings at Presentation and After Treatment of Patients With Congenital Glaucoma
Examination

2-mo Follow-Up
IOP During
Follow-up,
Range (Mean),
mm Hg

Corneal
Mean
Diameter,
Cup-Disc
Range
(Mean), mm Ratio

Mean
Cup-Disc
Ratio

IOP, mm Hg

IOP During
Follow-up,
mm Hg

Findings

Treatment

1/4.5

OD, 44.5;
OS, 46.4

OD, 13.1;
OS, 13.0

OD, 0.7;
OS, 0.7

Epiphora,
photophobia,
blepharospasm, no
anterior uveitis, and
corneal enlargement
and edema

Combined
trabeculotomy
and
trabeculectomy

OD,
17.2-21.3
(19.25);
OS, 16.5-22.4
(19.45)

OD,
12.9-12
(12.45);
OS,
12.8-12.1
(12.45)

OD, 0.7;
OS, 0.7

Corneal scar and
haze, optic nerve
atrophy

2/3.1

OD, 49.8;
OS, 50.9

OD, 12.2;
OS, 12.0

OD, 0.7;
OS, 0.7

Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos, and
corneal enlargement
and edema

Combined
trabeculotomy
and
trabeculectomy

OD,
12.4-17.4
(14.9);
OS, 13.6-16.1
(14.8)

OD,
12-11.7
(11.85);
OS,
11.9-11.5
(11.7)

OD, 0.7;
OS, 0.7

Corneal scar
and haze

3/6.6

OD, 76.1;
OS, 70.1

OD, 13.0;
OS, 12.9

OD, 0.8;
OS, 0.8

Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos,
corneal enlargement
and edema, and Haab
striae

Combined
trabeculotomy
and
trabeculectomy
and 1
IOP-lowering
medication

OD,
21.4-22.5
(21.9);
OS, 18.4-19.3
(18.8)

OD,
12.5-12.5
(12.5);
OS,
12.7-12.5
(12.6)

OD, 0.8;
OS, 0.8

Corneal scar and
haze, optic nerve
atrophy, Haab
striae

4/2.1

OD, 65.5;
OS, 46.7

OD, 12.6;
OS, 12.8

OD, 0.7;
OS, 0.7

Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos,
corneal enlargement
and edema, Haab
striae, and optic disc
cupping

Combined
trabeculotomy
and
trabeculectomy

OD, 16.8-21.2
(19);
OS, 12.7-18.9
(15.8)

OD,
12.1-11.9
(12.0);
OS,
12.4-12.3
(12.35)

OD, 0.7;
OS, 0.7

Corneal scar and
haze, Haab striae

5/1.8

OD, 51.1;
OS, 72.9

OD, 12.9;
OS, 12.9

OD, 0.7;
OS, 0.7

Epiphora,
photophobia,
blepharospasm,
no anterior uveitis,
buphthalmos,
corneal enlargement
and edema, and Haab
striae

Combined
trabeculotomy
and
trabeculectomy

OD,
14.4-16.9
(15.6);
OS, 18.3-19.1
(18.7)

OD,
12.7-12.6
(12.65);
OS,
12.0-12.0
(12.0)

OD, 0.7
OS, 0.7

Corneal scar and
haze, optic nerve
atrophy, Haab
striae

Patient
No./Age,
mo

Findings

Abbreviation: IOP, intraocular pressure.

reported in this series includes many other infections, such as
toxoplasmosis, cytomegalovirus infection, rubella, herpes simplex virus infection, and syphilis. However, these infections are
easily ruled out with neonatal testing.

Limitations
Our study is limited by its retrospective nature and the fact that
the mothers were clinically diagnosed as having Zika virus infection based on personal history. In addition, clinical criteria were
used to diagnose Zika virus infection, and the diagnosis was presumptive. Furthermore, our study evaluated the ophthalmic
manifestations in congenital Zika syndrome with microcephaly.
Of note, microcephaly is not required for the diagnosis of congenital Zika syndrome. Therefore, ocular features may have been
missed because of this exclusion criteria. However, the population sample of this study is representative of a random sample
of the Colombian and Venezuelan populations living in hot and
humid areas below an altitude of 2000 m. Furthermore, these
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infants were born after a Zika virus outbreak in Colombia and Venezuela. This study presents previously unreported ocular findings in congenital Zika syndrome for the region.

Conclusions
Forty-three infants with congenital Zika syndrome had severe ocular abnormalities, and all patients had bilateral involvement. The posterior ocular findings were focal pigment
mottling, chorioretinal atrophy with a predilection for the
macular area, congenital glaucoma and optical nerve hypoplasia, and optic disc abnormalities. Our data revealed that 12%
(95% CI, 5%-24%) of cases of congenital Zika with microcephaly had anterior segment abnormalities and 88% (95% CI,
76%-94%) had important macular and optic nerve abnormalities. Ophthalmic examination is recommended in patients with
congenital Zika syndrome.
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